Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
מצבים רפואיים
Metastatic Colorectal Cancer · BRAF V600E Mutation
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Kantonsspital Aarau, Aarau, Switzerland
Contact: Principal Investigator (Peter Moosmann, MD et phil.)Kantonsspital Baden, Baden, Switzerland
Contact: Principal Investigator (Stefanie Pederiva, MD)St. Claraspital, Basel, Switzerland
Contact: Study coordinator (Melanie Löffler-Baumann, MD) · melanie.loeffler-baumann@claraspital.ch · +41 61 685 85 85Contact: Principal Investigator (Melanie Löffler-Baumann, MD)Universitaetsspital Basel, Basel, Switzerland
Contact: Principal Investigator (Viviane Prof Hess)Inselspital Bern, Bern, Switzerland
Contact: Principal Investigator (Martin Berger, Prof)Spitalzentrum Biel - MEDIN La Tour, Biel, Switzerland
Contact: Principal Investigator (Emanuel Bührer, MD)Kantonsspital Graubünden, Chur, Switzerland
Contact: Principal Investigator (Sara Bastian, MD)Luzerner Kantonsspital, Lucerne, Switzerland
Contact: Principal Investigator (Simon Häfliger, MD)HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen, Switzerland
Contact: Principal Investigator (Barbara Denecke, MD)Bürgerspital Solothurn, Solothurn, Switzerland
Contact: Study coordinator (Julian Schardt, MD et phil.) · julian.schardt@spital.so.ch · +41 32 627 47 26Contact: Principal Investigator (Julian Schardt, MD et phil.)HFR Freiburg - Kantonsspital, Villars-sur-Glâne, Switzerland
Contact: Principal Investigator (Rahel Odermatt, MD)Kantonsspital Winterthur, Winterthur, Switzerland
Contact: Study coordinator (Guacimara Ortega Sanchez, MD) · guacimara.ortegasanchez@ksw.ch · +41 52 266 25 43Contact: Principal Investigator (Guacimara Ortega Sanchez, MD)Universitätsspital Zürich USZ, Zurich, Switzerland
Contact: Principal Investigator (Ralph Fritsch, MD)
מובילי המחקר
Ralph Fritsch, MD
Study Chair
University of Zurich